Family Dinner

Umass Extension 4-H, managed by the School of Nutrition at the University of Massachusetts flagship campus in Amherst, collaborates with various agencies and organizations in Charlestown, MA to offer family nutrition education programs. They provide three research-based programs focusing on family nutrition, food and nutrition education, and food safety education. Partnering with the Boston Public School System, the Boys and Girls Club, Head Start, and other entities, Umass Extension 4-H aims to promote healthy eating habits and food safety awareness within the community through their diverse educational initiatives. Generated from their available business information

Labby is a pioneering company based in Rochester, New York, that specializes in advanced milk testing solutions for dairy farmers. Utilizing cutting-edge mobile spectroscopy and artificial intelligence, Labby's technology provides real-time analysis of milk composition, enabling early mastitis detection and optimizing feed management to enhance overall herd health. Recognized for its innovative approach, Labby has received multiple accolades, including being named a finalist in the Farm Bureau Ag Innovation Challenge and winning the Best Tech Startup award from Tech Rochester. The company's mission is to improve milk quality and cow welfare through data-driven insights and rapid testing capabilities, significantly reducing costs for farmers. Generated from the website

Gritstone Oncology is a biotechnology company based in Cambridge, MA, that is dedicated to developing innovative immunotherapies for cancer and infectious diseases. Their approach involves harnessing the power of the patient's immune system to recognize and destroy tumors or virally infected cells, with a focus on T cell recognition and proliferation. Through their proprietary platforms, Gritstone has developed a portfolio of immunotherapies designed to activate and direct the immune system, offering new opportunities for more patients to benefit from immunotherapy. With a strong emphasis on personalized medicine, Gritstone is developing individualized cancer vaccines, known as GRANITE, that target neoantigens specific to each patient. They are also working on off-the-shelf immunotherapies, known as SLATE, which utilize shared neoantigens derived from driver mutations. In addition to their cancer vaccine programs, Gritstone is leveraging their core technologies to develop next-generation vaccines for infectious diseases, including a collaboration with Gilead Sciences to research and develop a vaccine-based immunotherapy for HIV infection. Their facilities in Pleasanton, CA, Emeryville, CA, and Cambridge, MA, house their manufacturing capabilities, research labs, and development teams.Generated from the website